• Portal do Governo Brasileiro
  • Atualize sua Barra de Governo
Logo
    • English
    • español
    • português (Brasil)
    • English
    • español
    • português (Brasil)
  • xmlui.dri2xhtml.structural.login
xmlui.ArtifactBrowser.ItemViewer.trail 
  •   xmlui.general.dspace_home
  • SEÇÃO DE ARBOVIROLOGIA E FEBRES HEMORRÁGICAS
  • SAARB - Artigos Científicos
  • xmlui.ArtifactBrowser.ItemViewer.trail
  •   xmlui.general.dspace_home
  • SEÇÃO DE ARBOVIROLOGIA E FEBRES HEMORRÁGICAS
  • SAARB - Artigos Científicos
  • xmlui.ArtifactBrowser.ItemViewer.trail
JavaScript is disabled for your browser. Some features of this site may not work without it.

Yellow fever virus: historical and current issues regarding recent epidemics and vaccination in Brazil

Thumbnail
xmlui.dri2xhtml.METS-1.0.item-date
2020
xmlui.dri2xhtml.METS-1.0.item-files-viewOpen
Yellow fever virus: historical and current issues regarding recent epidemics and vaccination in Brazil.pdf (816.1xmlui.dri2xhtml.METS-1.0.size-kilobytes)
xmlui.mirage2.itemSummaryView.MetaData
xmlui.ArtifactBrowser.ItemViewer.show_full
xmlui.dri2xhtml.METS-1.0.item-uri
http://patua.iec.gov.br//handle/iec/3994
xmlui.dri2xhtml.METS-1.0.item-author
Ishak, Ricardo
Ishak, Marluísa de Oliveira Guimarães
Vallinoto, Antonio Carlos Rosário
Pinheiro, Francisco de Paula
xmlui.dri2xhtml.METS-1.0.item-abstract
Yellow fever has been recently described in nonurban areas of Brazil despite 80 years of commercial vaccine use. Although the disease does not spread fear in the general population as it did in the past, yellow fever virus continues to cause many cases of severe disease. Persistence of the virus in the host is a new mechanism to be considered in the pathology of the disease. Immunization with a fractional dose of vaccine during emergency situations needs to be evaluated for antibody duration, and new and improved vaccines should be considered.
xmlui.dri2xhtml.METS-1.0.item-citation
ISHAK, Ricardo et al. Yellow fever virus: historical and current issues regarding recent epidemics and vaccination in Brazil. Human Vaccines and Immunotherapeutics, v. 16, n. 4, p. 900-903, Apr. 2020.
xmlui.dri2xhtml.METS-1.0.item-decsPrimary
Febre Amarela
Vacina contra Febre Amarela
Vírus da Febre Amarela / patogenicidade
Prevalência
Monitoramento Epidemiológico
xmlui.dri2xhtml.METS-1.0.item-rights
Acesso Aberto
xmlui.mirage2.itemSummaryView.Collections
  • SAARB - Artigos Científicos

Instituto Evandro Chagas - SVS - MS - 2007-2018 Rodovia BR316 km 7 sn - Levilandia - 67030-000 - Ananindeua - Para - Brasil.
Licença Creative CommonsEste trabalho está licenciado com uma Licença Creative Commons - Atribuição-NãoComercial 4.0 Internacional
Tel: (55 91) 3214-2191
Email: biblioteca@iec.gov.br / clariceneta@iec.gov.br
 

 

xmlui.ArtifactBrowser.Navigation.head_browse

xmlui.ArtifactBrowser.Navigation.head_all_of_dspacexmlui.ArtifactBrowser.Navigation.communities_and_collectionsxmlui.ArtifactBrowser.Navigation.browse_dateissuedxmlui.ArtifactBrowser.Navigation.browse_authorxmlui.ArtifactBrowser.Navigation.browse_titlexmlui.ArtifactBrowser.Navigation.browse_subjectxmlui.ArtifactBrowser.Navigation.head_this_collectionxmlui.ArtifactBrowser.Navigation.browse_dateissuedxmlui.ArtifactBrowser.Navigation.browse_authorxmlui.ArtifactBrowser.Navigation.browse_titlexmlui.ArtifactBrowser.Navigation.browse_subject

xmlui.EPerson.Navigation.my_account

xmlui.EPerson.Navigation.loginxmlui.EPerson.Navigation.register

Instituto Evandro Chagas - SVS - MS - 2007-2018 Rodovia BR316 km 7 sn - Levilandia - 67030-000 - Ananindeua - Para - Brasil.
Licença Creative CommonsEste trabalho está licenciado com uma Licença Creative Commons - Atribuição-NãoComercial 4.0 Internacional
Tel: (55 91) 3214-2191
Email: biblioteca@iec.gov.br / clariceneta@iec.gov.br